Skip to main content
Neurotherapeutics logoLink to Neurotherapeutics
. 2010 Jan;7(1):3–12. doi: 10.1016/j.nurt.2009.10.023

Cell death mechanisms and modulation in traumatic brain injury

Bogdan A Stoica 1,, Alan I Faden 1
PMCID: PMC2841970  NIHMSID: NIHMS169842  PMID: 20129492

Summary

Cell death after traumatic brain injury (TBI) is a major cause of neurological deficits and mortality. Understanding the mechanisms of delayed post-traumatic cell loss may lead to new therapies that improve outcome. Although TBI induces changes in multiple cell types, mechanisms of neuronal cell death have been the predominant focus. Recent work has emphasized the diversity of neuronal death phenotypes, which have generally been defined by either morphological or molecular changes. This diversity has led to confusing and at times contradictory nomenclature. Here we review the historical basis of proposed definitions of neuronal cell death, with the goal of clarifying critical research questions and implications for therapy in TBI. We believe that both morphological and molecular features must be used to clarify post-traumatic cell death and related therapeutic targets. Further, we underscore that the most effective neuroprotective strategies will need to target multiple pathways to reflect the regional and temporal changes underlying diverse neuronal cell death phenotypes.

Key Words: TBI, PCD, apoptosis, neurons

References

  • 1.Eldadah BA, Faden AI. Caspase pathways, neuronal apoptosis, and CNS injury. J Neurotrauma. 2000;17:811–829. doi: 10.1089/neu.2000.17.811. [DOI] [PubMed] [Google Scholar]
  • 2.Yu SW, Andrabi SA, Wang H, et al. Apoptosis-inducing factor mediates poly(ADP-ribose) (PAR) polymer-induced cell death. Proc Natl Acad Sci U S A. 2006;103:18314–18319. doi: 10.1073/pnas.0606528103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Formigli L, Papucci L, Tani A, et al. Aponecrosis: morphological and biochemical exploration of a syncretic process of cell death sharing apoptosis and necrosis. J Cell Physiol. 2000;182:41–49. doi: 10.1002/(SICI)1097-4652(200001)182:1<41::AID-JCP5>3.0.CO;2-7. [DOI] [PubMed] [Google Scholar]
  • 4.Majno G, Joris I. Apoptosis, oncosis, and necrosis: an overview of cell death. Am J Pathol. 1995;146:3–15. [PMC free article] [PubMed] [Google Scholar]
  • 5.Rokitansky C. Handbook of general pathological anatomy. Vienna: Braumüller & Seidel; 1842. [Google Scholar]
  • 6.Virchow R. Cellular pathology as based upon physiological and pathological histology. Berlin: Hirschwald; 1858. [DOI] [PubMed] [Google Scholar]
  • 7.Weigert C. An experimental and anatomical contribution to the pathology of specific types of inflammation. Virchows Arch Pathol Anat. 1878;72:461–501. [Google Scholar]
  • 8.Schmaus H, Albrecht E. On karyorrhexis. Virchows Arch Pathol Anat. 1894;138:1–80. [Google Scholar]
  • 9.Amheim G. Coagulation necrosis and atrophy of the cell nucleus. Virchows Arch Pathol Anat Physiol Klin Med. 1890;120:367–383. [Google Scholar]
  • 10.Klebs E. General pathology. Jena: Gustav Fischer; 1889. [Google Scholar]
  • 11.Flemming W. On the development of mammalian polar bodies within regressing Graafian follicles [Über die Bildung von Richtungsfiguren in Säugethiereiem beim Untergang Graaf’scher Follikel] [In German]. Arch Anat Entwgesch 1885;221–244.
  • 12.Nissen F. On the behavior of the nuclei in mammary gland cells during secretion. Arch Mikroskop Anat. 1886;26:337–342. [Google Scholar]
  • 13.Ströbe H. Toward understanding of various cellular phenomena in tumors. Beitr Pathol Anat. 1892;11:1–38. [Google Scholar]
  • 14.Glücksmann A. Cell deaths in normal vertebrate ontogeny. Biol Rev Camb Philos Soc. 1951;26:59–86. doi: 10.1111/j.1469-185x.1951.tb00774.x. [DOI] [PubMed] [Google Scholar]
  • 15.Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26:239–257. doi: 10.1038/bjc.1972.33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Kerr JF. Shrinkage necrosis: a distinct mode of cellular death. J Pathol. 1971;105:13–20. doi: 10.1002/path.1711050103. [DOI] [PubMed] [Google Scholar]
  • 17.Kerr JF. History of the events leading to the formulation of the apoptosis concept. Toxicology. 2002;181–182:471–474. doi: 10.1016/s0300-483x(02)00457-2. [DOI] [PubMed] [Google Scholar]
  • 18.Wyllie AH. Death in normal and neoplastic cells. J Clin Pathol Suppl (R Coll Pathol) 1974;7:35–42. [PMC free article] [PubMed] [Google Scholar]
  • 19.Wyllie AH. Cell death: a new classification separating apoptosis from necrosis. In: Bowen ID, Lockshin RA, editors. Cell death in biology and pathology. London; New York: Chapman & Hall; 1981. pp. 9–34. [Google Scholar]
  • 20.Schweichel JU, Merker HJ. The morphology of various types of cell death in prenatal tissues. Teratology. 1973;7:253–266. doi: 10.1002/tera.1420070306. [DOI] [PubMed] [Google Scholar]
  • 21.Clarke PG. Developmental cell death: morphological diversity and multiple mechanisms. Anat Embryol (Berl) 1990;181:195–213. doi: 10.1007/BF00174615. [DOI] [PubMed] [Google Scholar]
  • 22.Trump BF, Mergner WJ. Cell Injury. In: Zweifach BW, Grant L, McCluskey RT, editors. The inflammatory process. New York: Academic Press; 1974. pp. 115–257. [Google Scholar]
  • 23.Kroemer G, El-Deiry WS, Golstein P, et al. Nomenclature Committee on Cell Death. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death. Cell Death Differ. 2005;12(Suppl 2):1463–1467. doi: 10.1038/sj.cdd.4401724. [DOI] [PubMed] [Google Scholar]
  • 24.Majno G, Joris I. Commentary: on the misuse of the term “necrosis”: a step in the right direction. Toxicol Pathol. 1999;27:494–494. doi: 10.1177/019262339902700422. [DOI] [PubMed] [Google Scholar]
  • 25.Recklinghausen F v. Investigations of rickets and osteomalacia. Jena: Gustav Fischer; 1910. [Google Scholar]
  • 26.Van Cruchten S, Van Den Broeck W. Morphological and biochemical aspects of apoptosis, oncosis and necrosis. Anat Histol Embryol. 2002;31:214–223. doi: 10.1046/j.1439-0264.2002.00398.x. [DOI] [PubMed] [Google Scholar]
  • 27.Levin S, Bucci TJ, Cohen SM, et al. The nomenclature of cell death: recommendations of an ad hoc Committee of the Society of Toxicologie Pathologists. Toxicol Pathol. 1999;27:484–490. doi: 10.1177/019262339902700419. [DOI] [PubMed] [Google Scholar]
  • 28.Zychlinsky A, Sansonetti PJ. Apoptosis as a proinflammatory event: what can we learn from bacteria-induced cell death? Trends Microbiol. 1997;5:201–204. doi: 10.1016/S0966-842X(97)01044-5. [DOI] [PubMed] [Google Scholar]
  • 29.Bredesen DE. Neural apoptosis. Ann Neurol. 1995;38:839–851. doi: 10.1002/ana.410380604. [DOI] [PubMed] [Google Scholar]
  • 30.Bonfoco E, Krainc D, Ankarcrona M, Nicotera P, Lipton SA. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-d-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc Natl Acad Sci U S A. 1995;92:7162–7166. doi: 10.1073/pnas.92.16.7162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Turmaine M, Raza A, Mahal A, Mangiarini L, Bates GP, Davies SW. Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington’s disease. Proc Natl Acad Sci U S A. 2000;97:8093–8097. doi: 10.1073/pnas.110078997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Bittigau P, Sifringer M, Pohl D, et al. Apoptotic neurodegeneration following trauma is markedly enhanced in the immature brain. Ann Neurol. 1999;45:724–735. doi: 10.1002/1531-8249(199906)45:6<724::aid-ana6>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  • 33.Lockshin RA, Williams CM. Programmed cell death. II. Endocrine potentiation of the breakdown of the intersegmental muscles of silkmoths. J Insect Physiol. 1964;10:643–649. [Google Scholar]
  • 34.Schwartz LM, Smith SW, Jones ME, Osbome BA. Do all programmed cell deaths occur via apoptosis? Proc Natl Acad Sci U S A. 1993;90:980–984. doi: 10.1073/pnas.90.3.980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Sloviter RS. Apoptosis: a guide for the perplexed. Trends Pharmacol Sci. 2002;23:19–24. doi: 10.1016/s0165-6147(00)01867-8. [DOI] [PubMed] [Google Scholar]
  • 36.Bredesen DE. Key note lecture: toward a mechanistic taxonomy for cell death programs. Stroke. 2007;38:652–660. doi: 10.1161/01.STR.0000257802.82826.a7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Sperandio S, de Belle I, Bredesen DE. An alternative, nonapoptotic form of programmed cell death. Proc Natl Acad Sci U S A. 2000;97:14376–14381. doi: 10.1073/pnas.97.26.14376. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Dikranian K, Ishimaru MJ, Tenkova T, et al. Apoptosis in the in vivo mammalian forebrain. Neurobiol Dis. 2001;8:359–379. doi: 10.1006/nbdi.2001.0411. [DOI] [PubMed] [Google Scholar]
  • 39.Ishimaru MJ, Ikonomidou C, Tenkova TI, et al. Distinguishing excitotoxic from apoptotic neurodegeneration in the developing rat brain. J Comp Neurol. 1999;408:461–476. [PubMed] [Google Scholar]
  • 40.Bayly PV, Dikranian KT, Black EE, et al. Spatiotemporal evolution of apoptotic neurodegeneration following traumatic injury to the developing rat brain. Brain Res. 2006;1107:70–81. doi: 10.1016/j.brainres.2006.05.102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Portera-Cailliau C, Rice DL, Martin LJ. Non-NMDA and NMDA receptor-mediated excitotoxic neuronal deaths in adult brain are morphologically distinct: further evidence for an apoptosis-necrosis continuum. J Comp Neurol. 1997;378:88–104. [PubMed] [Google Scholar]
  • 42.Fujikawa DG, Shinmei SS, Zhao S, Aviles ER. Caspase-dependent programmed cell death pathways are not activated in generalized seizure-induced neuronal death. Brain Res. 2007;1135:206–218. doi: 10.1016/j.brainres.2006.12.029. [DOI] [PubMed] [Google Scholar]
  • 43.Fujikawa DG, Ke X, Trinidad RB, Shinmei SS, Wu A. Caspase-3 is not activated in seizure-induced neuronal necrosis with inter-nucleosomal DNA cleavage. J Neurochem. 2002;83:229–240. doi: 10.1046/j.1471-4159.2002.01152.x. [DOI] [PubMed] [Google Scholar]
  • 44.Fujikawa DG. Confusion between neuronal apoptosis and activation of programmed cell death mechanisms in acute necrotic insults. Trends Neurosci. 2000;23:410–411. doi: 10.1016/s0166-2236(00)01601-5. [DOI] [PubMed] [Google Scholar]
  • 45.Bredesen DE. Programmed cell death mechanisms in neurological disease. Curr Nol Med. 2008;8:173–186. doi: 10.2174/156652408784221315. [DOI] [PubMed] [Google Scholar]
  • 46.Minambres E, Ballesteros MA, Mayorga M, et al. Cerebral apoptosis in severe traumatic brain injury patients: an in vitro, in vivo, and postmortem study. J Neurotrauma. 2008;25:581–591. doi: 10.1089/neu.2007.0398. [DOI] [PubMed] [Google Scholar]
  • 47.Stoica BA, Byrnes KR, Faden AI. Cell cycle activation and CNS injury. Neurotox Res. 2009;16:221–237. doi: 10.1007/s12640-009-9050-0. [DOI] [PubMed] [Google Scholar]
  • 48.Di Giovanni S, Movsesyan V, Ahmed F, et al. Cell cycle inhibition provides neuroprotection and reduces glial proliferation and scar formation after traumatic brain injury. Proc Natl Acad Sci U S A. 2005;102:8333–8338. doi: 10.1073/pnas.0500989102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Cernak I, Stoica B, Byrnes KR, Di Giovanni S, Faden AI. Role of the cell cycle in the pathobiology of central nervous system trauma. Cell Cycle. 2005;4:1286–1293. doi: 10.4161/cc.4.9.1996. [DOI] [PubMed] [Google Scholar]
  • 50.Hilton GD, Stoica BA, Byrnes KR, Faden AI. Roscovitine reduces neuronal loss, glial activation, and neurologic deficits after brain trauma. J Cereb Blood Flow Metab. 2008;28:1845–1859. doi: 10.1038/jcbfm.2008.75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Yakovlev AG, Faden AI. Caspase-dependent apoptotic pathways in CNS injury. Mol Neurobiol. 2001;24:131–144. doi: 10.1385/MN:24:1-3:131. [DOI] [PubMed] [Google Scholar]
  • 52.Qiu J, Whalen MJ, Lowenstein P, et al. Upregulation of the Fas receptor death-inducing signaling complex after traumatic brain injury in mice and humans. J Neurosci. 2002;22:3504–3511. doi: 10.1523/JNEUROSCI.22-09-03504.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Zhang X, Alber S, Watkins SC, et al. Proteolysis consistent with activation of caspase-7 after severe traumatic brain injury in humans. J Neurotrauma. 2006;23:1583–1590. doi: 10.1089/neu.2006.23.1583. [DOI] [PubMed] [Google Scholar]
  • 54.Yakovlev AG, Knoblach SM, Fan L, Fox GB, Goodnight R, Faden AI. Activation of CPP32-like caspases contributes to neuronal apoptosis and neurological dysfunction after traumatic brain injury. J Neurosci. 1997;17:7415–7424. doi: 10.1523/JNEUROSCI.17-19-07415.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Lamer SF, Hayes RL, McKinsey DM, Pike BR, Wang KK. Increased expression and processing of caspase-12 after traumatic brain injury in rats. J Neurochem. 2004;88:78–90. doi: 10.1046/j.1471-4159.2003.02141.x. [DOI] [PubMed] [Google Scholar]
  • 56.Knoblach SM, Nikolaeva M, Huang X, et al. Multiple caspases are activated after traumatic brain injury: evidence for involvement in functional outcome. J Neurotrauma. 2002;19:1155–1170. doi: 10.1089/08977150260337967. [DOI] [PubMed] [Google Scholar]
  • 57.Knoblach S, Fan L, Huang X, Krajewski S, Reed JC, Faden AI. Activation of caspase 3 and 9 after traumatic brain injury in the rat: treatment with a pan-caspase inhibitor improves outcome. Society Neurosci. 2000;26:2300–2300. [Google Scholar]
  • 58.Nakagawa T, Zhu H, Morishima N, et al. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β. Nature. 2000;403:98–103. doi: 10.1038/47513. [DOI] [PubMed] [Google Scholar]
  • 59.Nathoo N, Narotam PK, Agrawal DK, et al. Influence of apoptosis on neurological outcome following traumatic cerebral contusion. J Neurosurg. 2004;101:233–240. doi: 10.3171/jns.2004.101.2.0233. [DOI] [PubMed] [Google Scholar]
  • 60.Ravagnan L, Rounder T, Kroemer G. Mitochondria, the killer organelles and their weapons. J Cell Physiol. 2002;192:131–137. doi: 10.1002/jcp.10111. [DOI] [PubMed] [Google Scholar]
  • 61.van Loo G, Saelens X, van Gurp M, MacFarlane M, Martin SJ, Vandenabeele P. The role of mitochondrial factors in apoptosis: a Russian roulette with more than one bullet. Cell Death Differ. 2002;9:1031–1042. doi: 10.1038/sj.cdd.4401088. [DOI] [PubMed] [Google Scholar]
  • 62.Daugas E, Nochy D, Ravagnan L, et al. Apoptosis-inducing factor (AIF): a ubiquitous mitochondrial oxidoreductase involved in apoptosis. FEBS Lett. 2000;476:118–123. doi: 10.1016/s0014-5793(00)01731-2. [DOI] [PubMed] [Google Scholar]
  • 63.Suzuki S, Chuang LF, Doi RH, Bidlack JM, Chuang RY. Kappaopioid receptors on lymphocytes of a human lymphocytic cell line: morphine-induced up-regulation as evidenced by competitive RT-PCR and indirect immunofluorescence. Int Immunopharmacol. 2001;1:1733–1742. doi: 10.1016/s1567-5769(01)00083-2. [DOI] [PubMed] [Google Scholar]
  • 64.Li LY, Luo X, Wang X. Endonuclease G is an apoptotic DNase when released from mitochondria. Nature. 2001;412:95–99. doi: 10.1038/35083620. [DOI] [PubMed] [Google Scholar]
  • 65.Vahsen N, Candé C, Brière JJ, et al. AIF deficiency compromises oxidative phosphorylation. EMBO J. 2004;23:4679–4689. doi: 10.1038/sj.emboj.7600461. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Zhang X, Chen J, Graham SH, et al. Intranuclear localization of apoptosis-inducing factor (AIF) and large scale DNA fragmentation after traumatic brain injury in rats and in neuronal cultures exposed to peroxynitrite. J Neurochem. 2002;82:181–191. doi: 10.1046/j.1471-4159.2002.00975.x. [DOI] [PubMed] [Google Scholar]
  • 67.Cregan SP, Dawson VL, Slack RS. Role of AIF in caspase-dependent and caspase-independent cell death. Oncogene. 2004;23:2785–2796. doi: 10.1038/sj.onc.1207517. [DOI] [PubMed] [Google Scholar]
  • 68.Candé C, Vahsen N, Garrido C, Kroemer G. Apoptosis-inducing factor (AIF): caspase-independent after all. Cell Death Differ. 2004;11:591–595. doi: 10.1038/sj.cdd.4401400. [DOI] [PubMed] [Google Scholar]
  • 69.Hong SJ, Dawson TM, Dawson VL. Nuclear and mitochondrial conversations in cell death: PARP-1 and AIF signaling. Trends Pharmacol Sci. 2004;25:259–264. doi: 10.1016/j.tips.2004.03.005. [DOI] [PubMed] [Google Scholar]
  • 70.Whalen MJ, Clark RS, Dixon CE, et al. Reduction of cognitive and motor deficits after traumatic brain injury in mice deficient in poly(ADP-ribose) polymerase. J Cereb Blood Flow Metab. 1999;19:835–842. doi: 10.1097/00004647-199908000-00002. [DOI] [PubMed] [Google Scholar]
  • 71.Alano CC, Ying W, Swanson RA. Poly(ADP-ribose) polymerase-1-mediated cell death in astrocytes requires NAD+ depletion and mitochondrial permeability transition. J Biol Chem. 2004;279:18895–18902. doi: 10.1074/jbc.M313329200. [DOI] [PubMed] [Google Scholar]
  • 72.Ying W, Alano CC, Gamier P, Swanson RA. NAD+ as a metabolic link between DNA damage and cell death. J Neurosci Res. 2005;79:216–223. doi: 10.1002/jnr.20289. [DOI] [PubMed] [Google Scholar]
  • 73.Moubarak RS, Yuste VJ, Artus C, et al. Sequential activation of poly(ADP-ribose) polymerase 1, calpains, and Bax is essential in apoptosis-inducing factor-mediated programmed necrosis. Mol Cell Biol. 2007;27:4844–4862. doi: 10.1128/MCB.02141-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Galat A. Peptidylprolyl cis/trans isomerases (immunophilins): biological diversity-targets-functions. Curr Top Med Chem. 2003;3:1315–1347. doi: 10.2174/1568026033451862. [DOI] [PubMed] [Google Scholar]
  • 75.Candé C, Vahsen N, Kouranti I, et al. AIF and cyclophilin A cooperate in apoptosis-associated chromatinolysis. Oncogene. 2004;23:1514–1521. doi: 10.1038/sj.onc.1207279. [DOI] [PubMed] [Google Scholar]
  • 76.Zhu C, Wang X, Deinum J, et al. Cyclophilin A participates in the nuclear translocation of apoptosis-inducing factor in neurons after cerebral hypoxia-ischemia. J Exp Med. 2007;204:1741–1748. doi: 10.1084/jem.20070193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Parcellier A, Gurbuxani S, Schmitt E, Solary E, Garrido C. Heat shock proteins, cellular chaperones that modulate mitochondrial cell death pathways. Biochem Biophys Res Commun. 2003;304:505–512. doi: 10.1016/s0006-291x(03)00623-5. [DOI] [PubMed] [Google Scholar]
  • 78.Yasuda H, Shichinohe H, Kuroda S, Ishikawa T, Iwasaki Y. Neuroprotective effect of a heat shock protein inducer, gera-nylgeranylacetone in permanent focal cerebral ischemia. Brain Res. 2005;1032:176–182. doi: 10.1016/j.brainres.2004.11.009. [DOI] [PubMed] [Google Scholar]
  • 79.Lee SH, Kwon HM, Kim YJ, Lee KM, Kim M, Yoon BW. Effects of hsp70.1 gene knockout on the mitochondrial apoptotic pathway after focal cerebral ischemia. Stroke. 2004;35:2195–2199. doi: 10.1161/01.STR.0000136150.73891.14. [DOI] [PubMed] [Google Scholar]
  • 80.Beere HM, Wolf BB, Cain K, et al. Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nat Cell Biol. 2000;2:469–475. doi: 10.1038/35019501. [DOI] [PubMed] [Google Scholar]
  • 81.Gurbuxani S, Schmitt E, Candé C, et al. Heat shock protein 70 binding inhibits the nuclear import of apoptosis-inducing factor. Oncogene. 2003;22:6669–6678. doi: 10.1038/sj.onc.1206794. [DOI] [PubMed] [Google Scholar]
  • 82.Matsumori Y, et al. Hsp70 overexpression sequesters AIF and reduces neonatal hypoxic/ischemic brain injury. J Cereb Blood Flow Metab. 2005;25:899–910. doi: 10.1038/sj.jcbfm.9600080. [DOI] [PubMed] [Google Scholar]
  • 83.Volbracht C, Leist M, Kolb SA, Nicotera P. Apoptosis in caspase-inhibited neurons. Mol Med. 2001;7:36–48. [PMC free article] [PubMed] [Google Scholar]
  • 84.Proskuryakov SY, Konoplyannikov AG, Gabai VL. Necrosis: a specific form of programmed cell death? Exp Cell Res. 2003;283:1–16. doi: 10.1016/s0014-4827(02)00027-7. [DOI] [PubMed] [Google Scholar]
  • 85.Pohl D, Bittigau P, Ishimaru MJ, et al. N-methyl-d-aspartate antagonists and apoptotic cell death triggered by head trauma in developing rat brain. Proc Natl Acad Sci U S A. 1999;96:2508–2513. doi: 10.1073/pnas.96.5.2508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Chautan M, Chazal G, Cecconi F, Grass P, Golstein P. Interdigital cell death can occur through a necrotic and caspase-independent pathway. Curr Biol. 1999;9:967–970. doi: 10.1016/s0960-9822(99)80425-4. [DOI] [PubMed] [Google Scholar]
  • 87.Oppenheim RW, Flavell RA, Vinsant S, Prevette D, Kuan CY, Rakic P. Programmed cell death of developing mammalian neurons after genetic deletion of caspases. J Neurosci. 2001;21:4752–4760. doi: 10.1523/JNEUROSCI.21-13-04752.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Yu L, Alva A, Su H, et al. Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8. Science. 2004;304:1500–1502. doi: 10.1126/science.1096645. [DOI] [PubMed] [Google Scholar]
  • 89.Culmsee C, Zhu C, Landshamer S, et al. Apoptosis-inducing factor triggered by poly(ADP-Ribose) polymerase and bid mediates neuronal cell death after oxygen-glucose deprivation and focal cerebral ischemia. J Neurosci. 2005;25:10262–10272. doi: 10.1523/JNEUROSCI.2818-05.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Zhu C, Wang X, Huang Z, et al. Apoptosis-inducing factor is a major contributor to neuronal loss induced by neonatal cerebral hypoxia-ischemia. Cell Death Differ. 2007;14:775–784. doi: 10.1038/sj.cdd.4402053. [DOI] [PubMed] [Google Scholar]
  • 91.Faden AI. Neuroprotection and traumatic brain injury: theoretical option or realistic proposition. Curr Opin Neurol. 2002;15:707–712. doi: 10.1097/01.wco.0000044767.39452.bf. [DOI] [PubMed] [Google Scholar]
  • 92.Byrnes KR, Loane DJ, Faden AI. Metabotropic glutamate receptors as targets for multipotential treatment of neurological disorders. Neurotherapeutics. 2009;6:94–107. doi: 10.1016/j.nurt.2008.10.038. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 93.Faden AI, Stoica B. Neuroprotection: challenges and opportunities. Arch Neurol. 2007;64:794–800. doi: 10.1001/archneur.64.6.794. [DOI] [PubMed] [Google Scholar]
  • 94.Vink R, Nimmo AJ. Multifunctional drugs for head injury. Neurotherapeutics. 2009;6:28–42. doi: 10.1016/j.nurt.2008.10.036. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95.Stoica B, Byrnes K, Faden AI. Multifunctional drug treatment in neurotrauma. Neurotherapeutics. 2009;6:14–27. doi: 10.1016/j.nurt.2008.10.029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96.De Nicola AF, Labombarda F, Deniselle MC, et al. Progesterone neuroprotection in traumatic CNS injury and motoneuron degeneration. Front Neuroendocrinol. 2009;30:173–187. doi: 10.1016/j.yfrne.2009.03.001. [DOI] [PubMed] [Google Scholar]
  • 97.Faden AI, Knoblach SM, Movsesyan VA, Cernak I. Novel small peptides with neuroprotective and nootropic properties. J Alzheimers Dis. 2004;6:S93–S97. doi: 10.3233/jad-2004-6s603. [DOI] [PubMed] [Google Scholar]
  • 98.Xiong Y, Mahmood A, Chopp M. Emerging treatments for traumatic brain injury. Expert Opin Emerg Drugs. 2009;14:67–84. doi: 10.1517/14728210902769601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 99.Xiong Y, Chopp M, Lee CP. Erythropoietin improves brain mitochondrial function in rats after traumatic brain injury. Neurol Res. 2009;31:496–502. doi: 10.1179/174313208X353703. [DOI] [PubMed] [Google Scholar]
  • 100.Li B, Mahmood A, Lu D, et al. Simvastatin attenuates microglial cells and astrocyte activation and decreases interleukin-1β level after traumatic brain injury. Neurosurgery. 2009;65:179–185. doi: 10.1227/01.NEU.0000346272.76537.DC. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 101.Wu H, Lu D, Jiang H, et al. Increase in phosphorylation of Akt and its downstream signaling targets and suppression of apoptosis by simvastatin after traumatic brain injury. 2008;109:691–698. doi: 10.3171/JNS/2008/109/10/0691. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 102.LaPlaca MC, Zhang J, Raghupathi R, et al. Pharmacologic inhibition of poly(ADP-ribose) polymerase is neuroprotective following traumatic brain injury in rats. J Neurotrauma. 2001;18:369–376. doi: 10.1089/089771501750170912. [DOI] [PubMed] [Google Scholar]
  • 103.Clark RS, Vagni VA, Nathaniel PD, Jenkins LW, Dixon CE, Szabó C. Local administration of the poly(ADP-ribose) polymerase inhibitor INO-1001 prevents NAD+ depletion and improves water maze performance after traumatic brain injury in mice. J Neurotrauma. 2007;24:1399–1405. doi: 10.1089/neu.2007.0305. [DOI] [PubMed] [Google Scholar]
  • 104.Ringger NC, Tolentino PJ, McKinsey DM, Pike BR, Wang KK, Hayes RL. Effects of injury severity on regional and temporal mRNA expression levels of calpains and caspases after traumatic brain injury in rats. J Neurotrauma. 2004;21:829–841. doi: 10.1089/0897715041526177. [DOI] [PubMed] [Google Scholar]
  • 105.Liu CL, Chen S, Dietrich D, Hu BR. Changes in autophagy after traumatic brain injury. J Cereb Blood Flow Metab. 2008;28:674–683. doi: 10.1038/sj.jcbfm.9600587. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 106.Zhang YB, Li SX, Chen XP, et al. Autophagy is activated and might protect neurons from degeneration after traumatic brain injury. Neurosci Bull. 2008;24:143–149. doi: 10.1007/s12264-008-1108-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 107.Simard JM, Kent TA, Chen M, Tarasov KV, Gerzanich V. Brain oedema in focal ischaemia: molecular pathophysiology and theoretical implications. Lancet Neurol. 2007;6:258–268. doi: 10.1016/S1474-4422(07)70055-8. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Neurotherapeutics are provided here courtesy of Elsevier

RESOURCES